(NYSE:NNVC) Dropped some Solid news this morning and the market seems to like it!!
Any news with positive effects and outcome from clinical trials is GREAT News and (NYSE:NNVC) has done just that!!
In its most recent PR ( 30 minutes ago ) The company stated that its broad spectrum anti viral drug candidate NV-387 Has had an “ideal flat blood concentration profile upon administration”
We are not bio-chemist or doctors but we’ll take a crack at it.
When drugs are administered orally you may see a spike in blood concentration levels which can cause unwanted side effects.. With NV-387 those side effects seem to be limited because of the flat blood concentration profile..
Again we are not biochemist and we may have just butchered that BUT it seems to us that (NYSE:NNVC) is Cooking up a brew that combats lethal infections like hCoV- NL63 (a model for SARS-CoV-2, cause of COVID), RSV, as well as Influenza A/H3N2, with minimal side effects.. Again this is us trying to break this down!
What’s more important at the moment is that the market is liking every bit of this!!
The 1 month chart for this Stock is LOOKING like a rockstar! And the pre-market activity has put this at #1 on our list of stocks to watch into this open!!